Cargando…
Mycobacterium tuberculosis Inhibitors Based on Arylated Quinoline Carboxylic Acid Backbones with Anti-Mtb Gyrase Activity
New antitubercular agents with either a novel mode of action or novel mode of inhibition are urgently needed to overcome the threat of drug-resistant tuberculosis (TB). The present study profiles new arylated quinoline carboxylic acids (QCAs) having activity against replicating and non-replicating M...
Autores principales: | Quimque, Mark Tristan J., Go, Adrian D., Lim, Justin Allen K., Vidar, Warren S., Macabeo, Allan Patrick G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380224/ https://www.ncbi.nlm.nih.gov/pubmed/37511390 http://dx.doi.org/10.3390/ijms241411632 |
Ejemplares similares
-
Schiff Bases of Indoline-2,3-dione: Potential Novel Inhibitors of Mycobacterium Tuberculosis (Mtb) DNA Gyrase (†)
por: Aboul-Fadl, Tarek, et al.
Publicado: (2011) -
Recognition of DNA Supercoil Geometry by Mycobacterium
tuberculosis Gyrase
por: Ashley, Rachel E., et al.
Publicado: (2017) -
Suppression of gyrase-mediated resistance by C7 aryl fluoroquinolones
por: Malik, Muhammad, et al.
Publicado: (2016) -
The role of Ca(2+) in the activity of Mycobacterium tuberculosis DNA gyrase
por: Karkare, Shantanu, et al.
Publicado: (2012) -
A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus
por: Ganapathy, Uday S., et al.
Publicado: (2021)